Summary:
A 12 week, phase 2 randomized placebo controlled double blind study comparing the efficacy, safety and tolerability of study medication in subjects with high cholesterol not adequately controlled on stable statin therapy.
Qualified Participants Must:
• Have high cholesterol
•
Be on a stable dose of atorvastatin, rosuvastatin or simvastatin for at least 12 weeks prior to screening
Qualified Participants May Receive:
Compensation for time and travel along with lab work and free physical exam.